Article
Reversibility and therapeutic feasibility of DNM1L-associated neurodevelopmental disorders.
Experimental & molecular medicine - 1 Mar 2026
So Ki Hurn, Kim Se Hee, Jang Shinyoung, Sang Hyeun Deok, Yun Eun-Jin, Choi Hee-Jung, Chae Jong-Hee, Baek Seung Tae
Abstract excerpt
DNM1L-associated encephalopathy is a neurological disorder with a broad spectrum of symptoms associated with mutations in the DNM1L gene. Treatment primarily aims to alleviate symptoms, which is mostly ineffective as the underlying neuropathology is not well understood. Moreover, the progression and reversibility of the molecular pathology across the key developmental and postnatal stages have not been well...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
